Calculated
DCF
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
269.43 USD466.25 USD629.64 USD
-64.47%
466.25 USDCurrent price is 64.5% below the base model value.
C
HealthcareDiagnostics & ResearchUnited States
CRL.US · Charles River Laboratories International, Inc.
NYQ · US · USD
Latest price165.66 USD
30D-8.59%
Vs. base value+99.5%
Research summary
CRL.US latest organized financial period shows revenue declined -0.85% YoY and net income declined -1,502% YoY. Current price is about 166 USD, while the model base case is about 83.02 USD; the current price sits +99.5% versus the base case. This summary is intended for public-information research and model review.
Key financial trend
Annual financial metrics with switchable views. · Unit: USD
Revenue4B USD
Net income-144M USD
Free cash flow518M USD
Operating cash flow738M USD
Price trend
Price date: 2026/04/28 · Updated: 2026/04/29 07:25
Valuation model range
Hover each model row to inspect formulas and inputs.
Current price165.66 USD
Base value83.02 USD
Vs. base+99.5%
Price date2026/04/28
83.02 USD83.02 USD92.70 USD
+99.54%
Calculated
Owner Earnings
Uses recent net income as an owner-earnings proxy and discounts scenario growth.
79.10 USD73.94 USD92.70 USD
+124%
73.94 USDCurrent price is 124.1% above the base model value.
Calculated
Reverse DCF
Solves the forward FCF growth rate implied by the current price.
Implied growth2.4%
Current price implies roughly 2.4% annualized FCF growth.
2.4%Current price implies roughly 2.4% annualized FCF growth.
Calculated
Earnings Power Value
Estimates earnings power value without assuming growth.
83.02 USD83.02 USD83.02 USD
+99.54%
83.02 USDCurrent price is 99.6% above the base model value.
Updated: 2026/04/29 07:25
Ad placement
Quarterly and annual financial table
Financial DetailsShowing latest 5 / 9
| Period | Type | Revenue | Net Income | Free Cash Flow | Diluted EPS |
|---|---|---|---|---|---|
| 2025/12/30 | Annual | 4B USD | -144M USD | 518M USD | -2.91 |
| 2024/12/30 | Annual | 4B USD | 10M USD | 502M USD | 0.2 |
| 2023/12/30 | Annual | 4B USD | 475M USD | 365M USD | 9.22 |
| 2022/12/30 | Annual | 4B USD | 486M USD | 295M USD | 9.48 |
| 2021/12/30 | Annual | - | - | - | - |
Ad placement